Literature DB >> 28324034

Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.

Hélène Bry-Gauillard1,2,3, Florence Larrat-Ledoux1,2, Jean-Marc Levaillant1,4,5,3, Nathalie Massin3, Luigi Maione1,2,6,5, Isabelle Beau2,5,7, Nadine Binart5,7, Philippe Chanson1,2,5,7, Sylvie Brailly-Tabard1,6,5,7, Janet E Hall8,9, Jacques Young1,2,5,7.   

Abstract

CONTEXT: Isolated hypogonadotropic hypogonadism (IHH), characterized by gonadotropin deficiency and absent puberty, is very rare in women. IHH prevents pubertal ovarian stimulation, but anti-Müllerian hormone (AMH) and antral follicle count (AFC) have not been studied.
OBJECTIVES: (1) To compare, in IHH vs controls, AMH, ovarian volume (OV), and AFC. (2) To compare, in IHH, ovarian responses to recombinant human follicle-stimulating hormone (rhFSH) and rhFSH plus recombinant human luteinizing hormone (rhLH).
SUBJECTS: Sixty-eight IHH women; 51 matched healthy women.
METHODS: Serum LH, FSH, sex steroids, inhibin B (InhB), AMH, and OV and AFC (sonography) were compared. Ovarian response during rhFSH administration was assessed in 12 IHH women with low AMH levels and low AFC and compared with hormonal changes observed in six additional IHH women receiving rhFSH plus rhLH.
RESULTS: InhB was lower in IHH than in controls. AMH levels were also significantly lower in the patients, but two-thirds had normal values. Mean OV and total, larger, and smaller AFCs were lower in IHH than in controls. Ovarian stimulation by rhFSH led to a significant increase in serum estradiol and InhB levels and in the number of larger antral follicles. AMH and smaller AFC increased early during rhFSH stimulation but then declined despite continued stimulation. rhFSH plus rhLH stimulation led to a significantly higher increase in estradiol levels but to similar changes in circulating InhB and AMH than with rhFSH alone.
CONCLUSIONS: IHH women have both low AMH levels and low AFC. However, their decrease can be reversed by follicle-stimulating hormone. Serum AMH and AFC should not serve as prognostic markers of fertility in this population.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28324034     DOI: 10.1210/jc.2016-3799

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.

Authors:  Vitaly A Kushnir; David B Seifer; David H Barad; Aritro Sen; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2017-06-22       Impact factor: 3.412

2.  Long-Term Follow-Up and Treatment of a Female With Complete Estrogen Insensitivity.

Authors:  Soumia Brakta; Lynn P Chorich; Hyung-Goo Kim; Laurel A Coons; John A Katzenellenbogen; Janet E Hall; Kenneth S Korach; Lawrence C Layman
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

3.  Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.

Authors:  Robert P Millar; Charlotte Sonigo; Richard A Anderson; Jyothis George; Luigi Maione; Sylvie Brailly-Tabard; Philippe Chanson; Nadine Binart; Jacques Young
Journal:  J Endocr Soc       Date:  2017-10-16

Review 4.  Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS.

Authors:  Martina Capuzzo; Antonio La Marca
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-03       Impact factor: 5.555

5.  Performance characteristics of the Mindray chemiluminescence anti-Müllerian hormone assay.

Authors:  Jing-Jing Zhao; Chun-Min Kang; Peng Zhang; Lei Zheng
Journal:  J Clin Lab Anal       Date:  2021-03-04       Impact factor: 2.352

6.  Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology.

Authors:  Marlene Hager; Johannes Ott; Julian Marschalek; Marie-Louise Marschalek; Clemens Kinsky; Rodrig Marculescu; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2022-07-04       Impact factor: 4.982

7.  High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.

Authors:  Yaxin Guo; Shuai Liu; Shiqiao Hu; Fei Li; Lei Jin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

Review 8.  Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.

Authors:  Didier Dewailly; Anne-Laure Barbotin; Agathe Dumont; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-09       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.